Geode Capital Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-3
Closed -$6K – 5034
2022
Q2
$6K Hold
3
– – ﹤0.01% 5001
2022
Q1
$13K Buy
+3
New +$15.7K ﹤0.01% 4954

Other funds holding MTRI

Geode Capital Management's MTRI Position: Q3 2022 in Review

Geode Capital Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2022, closing a stake of 3 shares — an estimated $6K sold.

Geode Capital Management first reported a position in MTRI in Q1 2022 and held it in 2 quarters. The position peaked at $13K in Q1 2022. 7 funds tracked by Wall St. Rank hold MTRI as of Q3 2022.

  • Geode Capital Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Geode Capital Management sold 3 Mentari Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • Geode Capital Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Geode Capital Management's Mentari Therapeutics, Inc. Common Stock position peaked at $13K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.